Axel Bolte
2022
In 2022, Axel Bolte earned a total compensation of $2.2M as Former President and Chief Executive Officer at Inozyme Pharma, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $306,087 |
---|---|
Option Awards | $1,176,518 |
Salary | $559,676 |
Other | $169,094 |
Total | $2,211,375 |
Bolte received $1.2M in option awards, accounting for 53% of the total pay in 2022.
Bolte also received $306.1K in non-equity incentive plan, $559.7K in salary and $169.1K in other compensation.
Rankings
In 2022, Axel Bolte's compensation ranked 1,624th out of 5,736 executives tracked by ExecPay. In other words, Bolte earned more than 71.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,624 | 72nd |
Manufacturing | 836 | 73rd |
Chemicals And Allied Products | 329 | 77th |
Drugs | 305 | 77th |
Pharmaceutical Preparations | 219 | 77th |
Bolte's colleagues
We found two more compensation records of executives who worked with Axel Bolte at Inozyme Pharma in 2022.